Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026

Rhea-AI Summary

Lifecore Biomedical (NASDAQ: LFCR) will report first-quarter 2026 financial results for the period ended March 31, 2026, on Wednesday, May 6, 2026 before market open. Lifecore management will host a live webcast at 8:00 a.m. Eastern to discuss results. An archived webcast will be available on the company's Investor Events & Presentations page for 30 days.

News Market Reaction – LFCR

+2.63%

+2.63% Session close to close

In the Apr 30 session, LFCR gained 2.63%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the reporting date for Lifecore’s first-quarter 2026 results and a webcast at...

Analysis

This announcement sets the reporting date for Lifecore’s first-quarter 2026 results and a webcast at 8:00 a.m. Eastern, without adding new financial metrics. In context of earlier disclosures on revenue growth, guidance, leverage and preferred-stock terms, investors may use the upcoming call to reassess progress toward targeted margin and growth goals. Attention may also focus on internal control remediation efforts and any updates affecting previously registered resale shares.

Key Figures

Quarter end date: March 31, 2026 Earnings release date: May 6, 2026 Webcast time: 8:00 a.m. Eastern Time +3 more

6 metrics

Quarter end date March 31, 2026 First quarter 2026 reporting period

Earnings release date May 6, 2026 Planned release of Q1 2026 financial results before market open

Webcast time 8:00 a.m. Eastern Time Q1 2026 results webcast start time

Webcast archive period 30 days Length of time replay will be available on company website

Prior period end December 31, 2025 Fourth quarter and transition period referenced in prior earnings-date release

Prior webcast time 8:30 a.m. Eastern Start time for March 16, 2026 earnings webcast

Previous Earnings date Reports

1 past event · Latest: Mar 09 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Mar 09	Earnings date announcement	Neutral	-1.1%	Scheduled Q4 and transition-period results with pre-market webcast timing.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings-date scheduling news saw a modest negative reaction of -1.15%, indicating limited but slightly negative sensitivity to such announcements.

Recent Company History

This announcement sets the timing for Lifecore’s first-quarter 2026 results, continuing the pattern from the prior earnings-date release on March 9, 2026 that scheduled fourth quarter and transition-period results for March 16, 2026 with a pre-market webcast. Alongside earlier updates on financial performance and guidance in recent 8-K filings, today’s notice mainly confirms when investors will receive the next detailed update, rather than introducing new operational or financial metrics.

Key Terms

cdmo

1 terms

cdmo technical

"a fully integrated injectables contract development and manufacturing organization (“CDMO”)"

A contract development and manufacturing organization (CDMO) is a company that provides specialized services to help develop and produce pharmaceutical products for other businesses. Think of it as a contract factory that takes a company's recipe and makes the product on their behalf. For investors, CDMOs are important because they support the growth of pharmaceutical companies and can be key partners in bringing new medicines to market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Webcast Scheduled for Wednesday, May 6 at 8:00 a.m. Eastern

CHASKA, Minn., April 29, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the first quarter ended March 31, 2026, on Wednesday, May 6, 2026, before the market opens. At 8:00 a.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to discuss the results.

To listen to the live webcast, or access the archived webcast, please visit the Investor Events & Presentations page of Lifecore’s website at: https://ir.lifecore.com/events-presentations. Following the live webcast, an archived version of the webcast will be available on the company’s website for 30 days.
  
About Lifecore Biomedical 
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated injectables contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com

Jennifer Arcure (Media)
917-603-0681
jarcure@vidasp.com

Lifecore Biomedical
Ryan D. Lake (CFO)
952-368-6244
ryan.lake@lifecore.com

FAQ

When will Lifecore (LFCR) release Q1 2026 results and what time is the webcast?

Lifecore will release Q1 2026 results on May 6, 2026 before market open, with a webcast at 8:00 a.m. Eastern. According to Lifecore, senior management will host the live webcast to discuss the quarter and answer questions immediately following the release.

Where can investors access the Lifecore (LFCR) May 6, 2026 webcast and archived recording?

Investors can access the live and archived webcast on Lifecore's Investor Events & Presentations page. According to Lifecore, the archived version will be available on the company's website for 30 days after the live webcast.

Will Lifecore (LFCR) senior management participate in the Q1 2026 webcast on May 6?

Yes. Lifecore's senior management team will host the May 6 webcast at 8:00 a.m. Eastern. According to Lifecore, management will discuss the Q1 2026 results and provide commentary for investors during the live presentation and archived replay.

Do I need to register to listen to Lifecore (LFCR) Q1 2026 webcast on May 6, 2026?

The announcement directs listeners to the company's Investor Events page to access the webcast; registration details are posted there. According to Lifecore, the webcast link and archived recording will be available through the Investor Events & Presentations page.

How long will the Lifecore (LFCR) Q1 2026 webcast remain available after the May 6 presentation?

The archived webcast will remain available for 30 days following the live May 6 presentation. According to Lifecore, investors can revisit the archived recording on the company's Investor Events & Presentations page during that 30-day window.